Skip to main content
C.Q. Pharmaceutical Holding Co., Ltd. logo

C.Q. Pharmaceutical Holding Co., Ltd. — Investor Relations & Filings

Ticker · 000950 ISIN · CNE0000010K0 Shenzhen Stock Exchange Wholesale and retail trade
Open in API
Filings indexed 2,882 across all filing types
Latest filing 2026-04-23 Notice of Dividend Amou…
Country CN China
Listing Shenzhen Stock Exchange 000950

About C.Q. Pharmaceutical Holding Co., Ltd.

https://www.cqphar.com

C.Q. Pharmaceutical Holding Co., Ltd. is a comprehensive pharmaceutical enterprise specializing in the distribution, retail, and supply chain management of healthcare products. The company operates an extensive network focused on the wholesale of pharmaceuticals and medical devices, providing integrated logistics and warehousing solutions to healthcare providers and manufacturers. Its core business activities encompass the procurement and distribution of a wide range of prescription drugs, over-the-counter medications, and specialized medical equipment. Through its retail pharmacy operations and third-party logistics services, the company facilitates the efficient delivery of medical supplies. C.Q. Pharmaceutical Holding Co., Ltd. emphasizes technological integration within its supply chain to optimize inventory management and ensure the integrity of healthcare products throughout the distribution lifecycle.

Recent filings

Filing Released Lang Actions
关于2025年度利润分配预案公告
Notice of Dividend Amount Classification · 95% confidence The document is titled as a "2025年度利润分配预案公告" which translates to "2025 Annual Profit Distribution Plan Announcement." It details the proposed cash dividend distribution plan for the fiscal year 2025, including the dividend per share, total dividend amount, board approval, and independent director opinions. The document includes specific financial figures related to net profit, equity, and dividend payout ratios. It also mentions the need for shareholder approval at the annual general meeting. The document is an announcement of the profit distribution plan rather than the full annual report or financial statements. It is not a full financial report but a formal announcement regarding dividend distribution plans and related board resolutions. Given the content and length (4256 characters), it fits best under the category of Notice of Dividend Amount (DIV).
2026-04-23 Chinese
2025年年度报告
Annual Report Classification · 100% confidence The document is titled '2025 年年度报告' which translates to '2025 Annual Report'. It contains detailed sections typical of an annual report such as company overview, financial data, management discussion and analysis, audit report references, and detailed financial metrics for the year 2025. The document length is substantial (15,000 characters), indicating it is the full report rather than a brief announcement. It includes signatures from company officers and auditors, financial statements, and comprehensive business and financial information. Therefore, this document fits the definition of an Annual Report (10-K). FY 2025
2026-04-23 Chinese
2025年度董事会工作报告
Board/Management Information Classification · 95% confidence The document is titled as the "2025年度董事会工作报告" which translates to "2025 Annual Board of Directors Work Report". It details the board's activities, meetings, resolutions, and governance practices throughout the year 2025. It includes financial performance summaries, board meeting details, committee activities, independent directors' work, information disclosure, and investor relations management. The document is comprehensive and focuses on the board's work and governance rather than being a full annual report or financial statement. It is not a simple announcement or certification but a detailed report on board and management activities. Therefore, it fits best under the category of Board/Management Information (MANG).
2026-04-23 Chinese
2025年度可持续发展报告
Environmental & Social Information Classification · 95% confidence The document is a detailed report covering the company's activities, performance, and initiatives related to Environmental, Social, and Governance (ESG) factors for the fiscal year 2025. It includes extensive information on ESG governance, social responsibility, environmental management, corporate culture, and strategic outlook. The document references the 2025 fiscal year and aligns with the company's annual reporting cycle. It is not a brief announcement or a presentation but a comprehensive report on ESG performance and sustainability practices. Therefore, it fits the category of Environmental & Social Information (SR).
2026-04-23 Chinese
2025年度内部控制评价报告
Audit Report / Information Classification · 95% confidence The document is titled '2025 年度内部控制评价报告' which translates to '2025 Annual Internal Control Evaluation Report'. It discusses the evaluation of the company's internal control effectiveness as of December 31, 2025, including financial and non-financial internal control defects, their classification, and remediation status. The document includes detailed internal control standards, evaluation scope, and conclusions about the effectiveness of internal controls. It is a comprehensive report on internal control evaluation rather than a brief announcement or certification. This type of document fits best under the category of Audit Report / Information (AR), as it is a standalone report focused on internal control evaluation and audit-related information, not a full annual report or other categories. FY 2025
2026-04-23 Chinese
关于“质量回报双提升”行动方案的进展公告
Regulatory Filings Classification · 95% confidence The document is an announcement from a listed company (重药控股股份有限公司) detailing the progress of its "Quality and Return Double Improvement" action plan for the year 2025. It includes operational updates, financial performance highlights (revenue, profit, net profit), dividend and share repurchase information, investor communication activities, ESG rating improvements, governance enhancements, and compliance training for key personnel. The document is structured as a progress update and corporate governance communication rather than a formal financial report or regulatory filing. It does not contain full financial statements or detailed quarterly or annual financial data, nor is it a transcript, proxy, or legal proceeding. The length is under 5,000 characters and it is a standalone announcement of progress and governance updates. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous corporate announcements that do not fit other specific categories.
2026-04-23 Chinese

Browse filings by year

27 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.